The Technical Analyst
Select Language :
Larimar Therapeutics Inc [LRMR]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Larimar Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Larimar Therapeutics Inc is listed at the  Exchange

4.47% $7.59

America/New_York / 28 mar 2024 @ 16:00


Larimar Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 484.24 mill
EPS: -0.840
P/E: -9.04
Earnings Date: May 12, 2024
SharesOutstanding: 63.80 mill
Avg Daily Volume: 0.606 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Sell
DE: Neutral
P/E: Strong Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -9.04 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-1.54x
Company: PE -9.04 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.483
(-93.64%) $-7.11
Date: 2024-03-28
Expected Trading Range (DAY)

$ 6.56 - 8.62

( +/- 13.60%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-16 Flynn James E Buy 1 430 206 Common Stock
2024-02-16 Flynn James E Buy 1 430 206 Common Stock
2024-02-16 Flynn James E Buy 1 430 205 Common Stock
2024-02-14 Thomas Frank E Buy 2 000 Common Stock
2024-01-17 Shankar Gopi Buy 135 000 Stock Option (Right to Buy)
INSIDER POWER
100.00
Last 91 transactions
Buy: 20 937 267 | Sell: 6 152 661

Forecast: 16:00 - $7.58

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $7.58
Forecast 2: 16:00 - $7.58
Forecast 3: 16:00 - $7.58
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $7.59 (4.47% )
Volume 0.515 mill
Avg. Vol. 0.606 mill
% of Avg. Vol 84.92 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Larimar Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Larimar Therapeutics Inc

RSI

Intraday RSI14 chart for Larimar Therapeutics Inc

Last 10 Buy & Sell Signals For LRMR

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 9 - 11:45buy$6.54N/AActive
Profile picture for
            Larimar Therapeutics Inc

LRMR

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Last 10 Buy Signals

Date Signal @
ATOMUSDMar 28 - 19:53$12.29
ONTUSDMar 28 - 19:49$0.372
CFXUSDMar 28 - 19:48$0.478
WOOUSDMar 28 - 19:47$0.462
BTCBUSDMar 28 - 19:4770 630
MKRUSDMar 28 - 19:46$3 638.71
AMKTUSDMar 28 - 19:44220.76
CTXCUSDMar 28 - 19:44$0.475
ARUSDMar 28 - 19:43$41.56
MXUSDMar 28 - 19:41$4.29

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.